KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Receivables - Net (2016 - 2026)

Abbott Laboratories' Receivables - Net history spans 18 years, with the latest figure at $8.2 billion for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 12.05% to $8.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.2 billion, a 12.05% increase, with the full-year FY2025 number at $7.9 billion, up 14.5% from a year prior.
  • Receivables - Net hit $8.2 billion in Q1 2026 for Abbott Laboratories, up from $7.9 billion in the prior quarter.
  • Over the last five years, Receivables - Net for ABT hit a ceiling of $8.2 billion in Q1 2026 and a floor of $6.0 billion in Q1 2023.
  • Historically, Receivables - Net has averaged $7.0 billion across 5 years, with a median of $6.9 billion in 2024.
  • Biggest five-year swings in Receivables - Net: increased 17.77% in 2022 and later dropped 16.14% in 2023.
  • Tracing ABT's Receivables - Net over 5 years: stood at $6.2 billion in 2022, then rose by 5.58% to $6.6 billion in 2023, then increased by 5.48% to $6.9 billion in 2024, then rose by 14.5% to $7.9 billion in 2025, then rose by 3.54% to $8.2 billion in 2026.
  • Business Quant data shows Receivables - Net for ABT at $8.2 billion in Q1 2026, $7.9 billion in Q4 2025, and $8.1 billion in Q3 2025.